4 recruiting, 2 unknown, 1 active not recruiting, 1 completed. 3 Phase 2, 2 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Not applicable | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Cell-Free Nucleic Acids: new trials by email Literature Review of Cell-Free Nucleic Acids trials Research Report on Cell-Free Nucleic Acids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility Study of Blood Biomarker Identification in Cervical Cancer Blood Sample Collection, cfDNA and Extracellular Vesicle Biomarker Analysis, Patient-Reported Outcome and Quality-of-Life Assessment - Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma | Recruiting | Queensland Centre for Gynaecological Cancer | 100 | 2026-09-15 | 2026-09-02 | |
| Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients Biospecimen Collection, cfDNA or ctDNA Measurement, Electronic Health Record Review - Resectable Colorectal Carcinoma, Stage II Colorectal Cancer AJCC v8 | Not applicable | Recruiting | City of Hope Medical Center | 150 | 2025-08-29 | 2026-08-12 |
| Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study Biospecimen Collection, cfDNA or ctDNA Measurement, Computed Tomography - Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma | Phase 2 / Phase 3 | Recruiting | National Cancer Institute (NCI) | 992 | 2024-02-02 | 2026-10-27 |
| CIRculating CANcer MAster-Protocol Blood sampling for biomarker analysis (microRNA, circulating DNA…) - Adult With Solid Cancer | Recruiting | Hospices Civils de Lyon | 6000 | 2022-12-05 | 2026-06-10 | |
| Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer Neoadjuvant chemotherapy with PSOX regimen., Detect the imaging data and levels of CTC, ctDNA, cfDNA, CEA, CA19-9, CA72-4 in plasma., Detect the tumor related DNA in pathological tissues after operation. - Gastric Cancer, Gastro-oesophageal Junction Cancer | Phase 2 | Unknown | Affiliated Hospital of Qinghai University | 40 | 2019-05-28 | 2020-01-22 |
| Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT Stereotactic Body Radiotherapy - Prostate Cancer, Radiotherapy Side Effects | Active not recruiting | NHS Lothian | 60 | 2018-10-11 | 2026-02-13 | |
| Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma Irinotecan, Ramucirumab, Blood for angiome profiling - Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma | Phase 2 | Completed | Washington University School of Medicine | 40 | 2017-11-01 | 2024-06-25 |
| Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence. follow up DW MRI - Melanoma | Not applicable | Unknown | Universitair Ziekenhuis Brussel | 100 | 2014-11-01 | 2020-12-17 |
Colorectal Neoplasms (1) · Melanoma (1) · Neoplastic Cells, Circulating (1) · Pathologic Complete Response (1) · Prostatic Neoplasms (1) · Stomach Neoplasms (1) · Uterine Cervical Neoplasms (1)
Affiliated Hospital of Qinghai University (1) · City of Hope Medical Center (1) · Hospices Civils de Lyon (1) · NHS Lothian (1) · National Cancer Institute (NCI) (1) · Queensland Centre for Gynaecological Cancer (1) · Universitair Ziekenhuis Brussel (1) · Washington University School of Medicine (1)
United States (3) · Australia (1) · Belgium (1) · Canada (1) · China (1) · France (1) · United Kingdom (1)
Bart Neyns, Md Phd (1) · Duncan B McLaren, MBBS (1) · Kian-Huat Lim, M.D., Ph.D. (1) · Marwan G Fakih (1) · Matthew D Galsky (1)
P30CA033572 (1), U10CA180821 (1)